{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:49:21Z","timestamp":1787503761506,"version":"build-2736575974"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:00:00Z","timestamp":1760745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00203-025-04497-8","type":"journal-article","created":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:27:30Z","timestamp":1760783250000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nanoparticle-mediated delivery of antimicrobial peptides for multidrug-resistant ventilator-associated pneumonia: a comprehensive review of a promising therapeutic strategy"],"prefix":"10.1007","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5248-5818","authenticated-orcid":false,"given":"S. Santhana","family":"Krishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. Nalini","family":"Jayanthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leela Kagithakara","family":"Vajravelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Santhiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,18]]},"reference":[{"key":"4497_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0307-4","author":"NM Adams","year":"2020","unstructured":"Adams NM, Grassmann S, Sun JC (2020) Clonal expansion of innate and adaptive lymphocytes. Nat Rev Immunol. https:\/\/doi.org\/10.1038\/s41577-020-0307-4","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"4497_CR2","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.63785\/cpr.2025.1.1.3044","volume":"1","author":"T Ali","year":"2025","unstructured":"Ali T (2025) Nanomedicine approaches to overcome barriers in pulmonary drug delivery for respiratory diseases. Curr Pharm Res 1(1):3044. https:\/\/doi.org\/10.63785\/cpr.2025.1.1.3044","journal-title":"Curr Pharm Res"},{"issue":"12","key":"4497_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11121731","volume":"11","author":"VT Anju","year":"2022","unstructured":"Anju VT, Busi S, Imchen M, Kumavath R, Mohan MS, Salim SA, Subhaswaraj P, Dyavaiah M (2022) Polymicrobial infections and biofilms: clinical significance and eradication strategies. Antibiotics 11(12):1731. https:\/\/doi.org\/10.3390\/antibiotics11121731","journal-title":"Antibiotics"},{"key":"4497_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2022.127155","volume":"264","author":"NJ Anyaegbunam","year":"2022","unstructured":"Anyaegbunam NJ, Anekpo CC, Anyaegbunam ZK, Doowuese Y, Chinaka CB, Odo OJ et al (2022) The resurgence of phage-based therapy in the era of increasing antibiotic resistance: from research progress to challenges and prospects. Microbiol Res 264:127155. https:\/\/doi.org\/10.1016\/j.micres.2022.127155","journal-title":"Microbiol Res"},{"key":"4497_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3389\/fmolb.2020.00193","volume":"7","author":"Y Ao","year":"2020","unstructured":"Ao Y, Zhou Y, Liu L, Xu Y, Chen Q, Wang Y, Wu S, Deng Y, Zhang J, Shao A (2020) Nanoparticle-Based drug delivery in cancer therapy and its role in overcoming drug resistance. Front Mol Biosci 7:193. https:\/\/doi.org\/10.3389\/fmolb.2020.00193","journal-title":"Front Mol Biosci"},{"issue":"5","key":"4497_CR6","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.bbamem.2015.10.013","volume":"1858","author":"G Batoni","year":"2016","unstructured":"Batoni G, Maisetta G, Esin S (2016) Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria. Biochimica et Biophysica Acta (BBA) 1858(5):1044\u20131060. https:\/\/doi.org\/10.1016\/j.bbamem.2015.10.013","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"2","key":"4497_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.micinf.2004.11.001","volume":"7","author":"RP Baughman","year":"2005","unstructured":"Baughman RP (2005) Diagnosis of ventilator-associated pneumonia. Microbes Infect 7(2):262\u2013267. https:\/\/doi.org\/10.1016\/j.micinf.2004.11.001","journal-title":"Microbes Infect"},{"issue":"3","key":"4497_CR8","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/cid\/ciy543","volume":"68","author":"A Bonell","year":"2019","unstructured":"Bonell A, Azarrafiy R, Huong VTL et al (2019) A systematic review and meta-analysis of ventilator-associated pneumonia in adults in Asia: an analysis of national income level on incidence and etiology. Clin Infect Dis 68(3):511\u2013518. https:\/\/doi.org\/10.1093\/cid\/ciy543","journal-title":"Clin Infect Dis"},{"key":"4497_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.micres.2024.127822","volume":"286","author":"C Bucataru","year":"2024","unstructured":"Bucataru C, Ciobanasu C (2024) Antimicrobial peptides: opportunities and challenges in overcoming resistance. Microbiol Res 286:127822. https:\/\/doi.org\/10.1016\/j.micres.2024.127822","journal-title":"Microbiol Res"},{"issue":"2","key":"4497_CR10","first-page":"140","volume":"7","author":"E Carrasco-Esteban","year":"2021","unstructured":"Carrasco-Esteban E, Dom\u00ednguez-Rull\u00e1n JA, Barrionuevo-Castillo P, Pelari-Mici L, Leaman O, Sastre-Gallego S, L\u00f3pez-Campos F (2021) Current role of nanoparticles in the treatment of lung cancer. J Clin Transl Res 7(2):140\u2013155 PMID:34104817; PMCID:PMC8177846","journal-title":"J Clin Transl Res"},{"issue":"4","key":"4497_CR11","doi-asserted-by":"publisher","DOI":"10.1208\/s12249-023-02559-y","volume":"24","author":"HW Chan","year":"2023","unstructured":"Chan HW, Chow S, Zhang X, Zhao Y, Tong HHY, Chow SF (2023) Inhalable nanoparticle-based dry powder formulations for respiratory diseases: challenges and strategies for translational research. AAPS PharmSciTech 24(4):98. https:\/\/doi.org\/10.1208\/s12249-023-02559-y","journal-title":"AAPS PharmSciTech"},{"key":"4497_CR12","doi-asserted-by":"publisher","first-page":"808","DOI":"10.3109\/10717544.2014.917130","volume":"23","author":"D Chen","year":"2016","unstructured":"Chen D, Lian S, Sun J, Liu Z, Zhao F, Jiang Y et al (2016) Design of novel multifunctional targeting nano-carrier drug delivery system based on CD44 receptor and tumor microenvironment pH condition. Drug Deliv 23:808\u2013813. https:\/\/doi.org\/10.3109\/10717544.2014.917130","journal-title":"Drug Deliv"},{"issue":"6","key":"4497_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/cc8174","volume":"13","author":"E Christaki","year":"2009","unstructured":"Christaki E (2009) Host immune response in sepsis due to ventilator-associated pneumonia: how is it different? Crit Care 13(6):1009. https:\/\/doi.org\/10.1186\/cc8174","journal-title":"Crit Care"},{"issue":"8","key":"4497_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ph17081059","volume":"17","author":"E Cojocaru","year":"2024","unstructured":"Cojocaru E, Petri\u0219 OR, Cojocaru C (2024) Nanoparticle-based drug delivery systems in inhaled therapy: improving respiratory medicine. Pharmaceuticals (Basel) 17(8):1059. https:\/\/doi.org\/10.3390\/ph17081059","journal-title":"Pharmaceuticals (Basel)"},{"issue":"6","key":"4497_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8060821","volume":"8","author":"A Cotoia","year":"2020","unstructured":"Cotoia A, Spadaro S, Gambetti G, Koulenti D, Cinnella G (2020) Pathogenesis-targeted preventive strategies for multidrug resistant ventilator-associated pneumonia: a narrative review. Microorganisms 8(6):821. https:\/\/doi.org\/10.3390\/microorganisms8060821","journal-title":"Microorganisms"},{"issue":"7","key":"4497_CR16","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1128\/AEM.03627-13","volume":"80","author":"N D\u2019Urzo","year":"2014","unstructured":"D\u2019Urzo N, Martinelli M, Pezzicoli A, De Cesare V, Pinto V, Margarit I, Telford JL, Maione D, Members of the DEVANI Study Group (2014) Acidic pH strongly enhances in vitro biofilm formation by a subset of hypervirulent ST-17 Streptococcus agalactiae strains. Appl Environ Microbiol 80(7):2176\u20132185. https:\/\/doi.org\/10.1128\/AEM.03627-13","journal-title":"Appl Environ Microbiol"},{"key":"4497_CR17","doi-asserted-by":"publisher","DOI":"10.15212\/bioi-2021-0003","author":"Y Deng","year":"2021","unstructured":"Deng Y, Huang R, Huang S, Xiong M (2021) Nanoparticles enable efficient delivery of antimicrobial peptides for the treatment of deep infections. BIO Integr. https:\/\/doi.org\/10.15212\/bioi-2021-0003","journal-title":"BIO Integr"},{"issue":"2","key":"4497_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2478\/jccm-2018-0011","volume":"4","author":"O Diaconu","year":"2018","unstructured":"Diaconu O, Siriopol I, Polo\u0219anu LI, Grigora\u0219 I (2018) Endotracheal tube biofilm and its impact on the pathogenesis of ventilator-associated pneumonia. The Journal of Critical Care Medicine 4(2):50\u201355. https:\/\/doi.org\/10.2478\/jccm-2018-0011","journal-title":"The Journal of Critical Care Medicine"},{"key":"4497_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1119574","volume":"14","author":"DI Duarte-Mata","year":"2023","unstructured":"Duarte-Mata DI, Salinas-Carmona MC (2023) Antimicrobial peptides\u2019 immune modulation role in intracellular bacterial infection. Front Immunol 14:1119574. https:\/\/doi.org\/10.3389\/fimmu.2023.1119574","journal-title":"Front Immunol"},{"issue":"2","key":"4497_CR20","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/bja\/aef169","volume":"89","author":"F Duflo","year":"2002","unstructured":"Duflo F, Debon R, Goudable J, Chassard D, Allaouchiche B (2002) Alveolar and serum oxidative stress in ventilator-associated pneumonia. Br J Anaesth 89(2):231\u2013236. https:\/\/doi.org\/10.1093\/bja\/aef169","journal-title":"Br J Anaesth"},{"issue":"11","key":"4497_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13111795","volume":"13","author":"A Fadaka","year":"2021","unstructured":"Fadaka A, Sibuyi NRS, Madiehe A, Meyer M (2021) Nanotechnology-based delivery systems for antimicrobial peptides. Pharmaceutics 13(11):1795. https:\/\/doi.org\/10.3390\/pharmaceutics13111795","journal-title":"Pharmaceutics"},{"key":"4497_CR22","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.2147\/IJN.S218966","volume":"15","author":"C Falciani","year":"2020","unstructured":"Falciani C, Zevolini F, Brunetti J, Riolo G, Gracia R, Marradi M et al (2020) Antimicrobial Peptide-Loaded nanoparticles as inhalation therapy for Pseudomonas aeruginosa infections. Int J Nanomed 15:1117\u20131128. https:\/\/doi.org\/10.2147\/IJN.S218966","journal-title":"Int J Nanomed"},{"issue":"7","key":"4497_CR23","doi-asserted-by":"publisher","first-page":"e2300712","DOI":"10.1002\/ardp.202300712","volume":"357","author":"NA Gaffar","year":"2024","unstructured":"Gaffar NA, Zahid M, Asghar A, Shafiq MF, Jelani S, Rehan F (2024) Biosynthesized metallic nanoparticles: a new era in cancer therapy. Arch Pharm 357(7):e2300712. https:\/\/doi.org\/10.1002\/ardp.202300712","journal-title":"Arch Pharm"},{"key":"4497_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122442","volume":"305","author":"Z Gao","year":"2024","unstructured":"Gao Z, Zhang J, Hou Y, Lu J, Liang J, Gao Y et al (2024) Boosting the synergism between cancer ferroptosis and immunotherapy via targeted stimuli-responsive liposomes. Biomaterials 305:122442. https:\/\/doi.org\/10.1016\/j.biomaterials.2023.122442","journal-title":"Biomaterials"},{"key":"4497_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-135","volume":"14","author":"J Garnacho-Montero","year":"2014","unstructured":"Garnacho-Montero J, Corcia-Palomo Y, Amaya-Villar R, Martin-Villen L (2014) How to treat VAP due to MDR pathogens in ICU patients. BMC Infect Dis 14:135. https:\/\/doi.org\/10.1186\/1471-2334-14-135","journal-title":"BMC Infect Dis"},{"key":"4497_CR26","doi-asserted-by":"publisher","first-page":"101616","DOI":"10.1016\/j.mtbio.2025.101616","volume":"31","author":"M George","year":"2025","unstructured":"George M, Boukherroub R, Sanyal A, Szunerits S (2025) Treatment of lung diseases via nanoparticles and nanorobots: are these viable alternatives to overcome current treatments? Mater Today Bio 31:101616. https:\/\/doi.org\/10.1016\/j.mtbio.2025.101616","journal-title":"Mater Today Bio"},{"issue":"1","key":"4497_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s43088-025-00646-6","volume":"14","author":"A Gholap","year":"2025","unstructured":"Gholap A, Pardeshi S, Giram P, Nangare S, Sodha S, Kapare H et al (2025) Breathing new life nanomedicines for pulmonary drug delivery: targeting approaches, experimental models, and regulatory aspects. Beni-Suef Univ J Basic Appl Sci 14(1):1\u201343. https:\/\/doi.org\/10.1186\/s43088-025-00646-6","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"issue":"11","key":"4497_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15112582","volume":"15","author":"Y Guo","year":"2023","unstructured":"Guo Y, Mao Z, Ran F, Sun J, Zhang J, Chai G, Wang J (2023) Nanotechnology-based drug delivery systems to control bacterial-biofilm-associated lung infections. Pharmaceutics 15(11):2582. https:\/\/doi.org\/10.3390\/pharmaceutics15112582","journal-title":"Pharmaceutics"},{"issue":"2","key":"4497_CR29","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/0972-5229.56048","volume":"13","author":"S Gupta","year":"2009","unstructured":"Gupta S, Govil D, Kakar PN, Prakash O, Arora D, Das S et al (2009) Colistin and polymyxin B: a re-emergence. Indian J Crit Care Med 13(2):49\u201353. https:\/\/doi.org\/10.4103\/0972-5229.56048","journal-title":"Indian J Crit Care Med"},{"key":"4497_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-015-0072-9","volume":"3","author":"M Gurjar","year":"2015","unstructured":"Gurjar M (2015) Colistin for lung infection: an update. J Intensive Care 3:3. https:\/\/doi.org\/10.1186\/s40560-015-0072-9","journal-title":"J Intensive Care"},{"key":"4497_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.12688\/f1000research.129080.1","volume":"12","author":"D Hammoudi Halat","year":"2024","unstructured":"Hammoudi Halat D, Ayoub Moubareck C (2024) Hospital-acquired and ventilator-associated pneumonia caused by multidrug-resistant Gram-negative pathogens: Understanding epidemiology, resistance patterns, and implications with COVID-19. F1000Res 12:92. https:\/\/doi.org\/10.12688\/f1000research.129080.1","journal-title":"F1000Res"},{"issue":"11","key":"4497_CR32","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.3390\/ph17111555","volume":"17","author":"HF Hetta","year":"2024","unstructured":"Hetta HF, Sirag N, Alsharif SM, Alharbi AA, Alkindy TT, Alkhamali A et al (2024) Antimicrobial peptides: the game-changer in the epic battle against multidrug-resistant bacteria. Pharmaceuticals (Basel) 17(11):1555. https:\/\/doi.org\/10.3390\/ph17111555","journal-title":"Pharmaceuticals (Basel)"},{"key":"4497_CR33","doi-asserted-by":"publisher","first-page":"6447","DOI":"10.1038\/s41467-024-50805-z","volume":"15","author":"F Howroyd","year":"2024","unstructured":"Howroyd F, Chacko C, MacDuff A et al (2024) Ventilator-associated pneumonia: Pathobiological heterogeneity and diagnostic challenges. Nat Commun 15:6447. https:\/\/doi.org\/10.1038\/s41467-024-50805-z","journal-title":"Nat Commun"},{"key":"4497_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2025.108275","volume":"247","author":"F Howroyd","year":"2025","unstructured":"Howroyd F, Gill R, Thompson J, Smith FG, Nasa P, Gopal S, Duggal NA, Ahmed Z, Veenith T (2025) Ventilator-associated pneumonia: mechanisms, an appraisal of current therapies and the role for inhaled antibiotics in prevention and treatment. Respir Med 247:108275. https:\/\/doi.org\/10.1016\/j.rmed.2025.108275","journal-title":"Respir Med"},{"key":"4497_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.582779","volume":"11","author":"Y Huan","year":"2020","unstructured":"Huan Y, Kong Q, Mou H, Yi H (2020) Antimicrobial peptides: classification, design, application and research progress in multiple fields. Front Microbiol 11:582779. https:\/\/doi.org\/10.3389\/fmicb.2020.582779","journal-title":"Front Microbiol"},{"key":"4497_CR36","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1007\/s13346-021-00954-1","volume":"11","author":"Z Huang","year":"2021","unstructured":"Huang Z, K\u0142odzi\u0144ska SN, Wan F et al (2021) Nanoparticle-mediated pulmonary drug delivery: state of the art towards efficient treatment of recalcitrant respiratory tract bacterial infections. Drug Deliv Transl Res 11:1634\u20131654. https:\/\/doi.org\/10.1007\/s13346-021-00954-1","journal-title":"Drug Deliv Transl Res"},{"key":"4497_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41392-024-01745-z","volume":"9","author":"Y Huang","year":"2024","unstructured":"Huang Y, Guo X, Wu Y et al (2024) Nanotechnology\u2019s frontier in combatting infectious and inflammatory diseases: prevention and treatment. Signal Transduct Target Ther 9:34. https:\/\/doi.org\/10.1038\/s41392-024-01745-z","journal-title":"Signal Transduct Target Ther"},{"key":"4497_CR38","doi-asserted-by":"publisher","first-page":"e3325","DOI":"10.1136\/bmj.e3325","volume":"344","author":"JD Hunter","year":"2012","unstructured":"Hunter JD (2012) Ventilator associated pneumonia. BMJ 344:e3325. https:\/\/doi.org\/10.1136\/bmj.e3325","journal-title":"BMJ"},{"key":"4497_CR39","doi-asserted-by":"publisher","first-page":"107661","DOI":"10.1016\/j.rmed.2024.107661","volume":"227","author":"N Islam","year":"2024","unstructured":"Islam N, Reid D (2024) Inhaled antibiotics: a promising drug delivery strategy for efficient treatment of lower respiratory tract infections (LRTIs) associated with antibiotic resistant biofilm-dwelling and intracellular bacterial pathogens. Rev Article 227:107661. https:\/\/doi.org\/10.1016\/j.rmed.2024.107661","journal-title":"Rev Article"},{"key":"4497_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3123","author":"A Iwasaki","year":"2015","unstructured":"Iwasaki A, Medzhitov R (2015) Control of adaptive immunity by the innate immune system. Nat Immunol. https:\/\/doi.org\/10.1038\/ni.3123","journal-title":"Nat Immunol"},{"issue":"36","key":"4497_CR41","doi-asserted-by":"publisher","first-page":"5233","DOI":"10.2174\/1381612821666150923095742","volume":"21","author":"R Iyer","year":"2015","unstructured":"Iyer R, Hsia CC, Nguyen KT (2015) Nano-Therapeutics for the lung: State-of-the-Art and future perspectives. Curr Pharm Des 21(36):5233\u20135244. https:\/\/doi.org\/10.2174\/1381612821666150923095742","journal-title":"Curr Pharm Des"},{"key":"4497_CR42","doi-asserted-by":"publisher","unstructured":"Kalanuria AA, Ziai W, Mirski M (2014) Ventilator-associated pneumonia in the ICU. Crit Care. ;18(2):208. https:\/\/doi.org\/10.1186\/cc13775. Erratum in: Crit Care. 2016;20:29. doi:10.1186\/s13054-016-1206-8","DOI":"10.1186\/cc13775"},{"issue":"5","key":"4497_CR43","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","volume":"63","author":"AC Kalil","year":"2016","unstructured":"Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB et al (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the infectious diseases society of America and the American thoracic society. Clin Infect Dis 63(5):e61\u2013111. https:\/\/doi.org\/10.1093\/cid\/ciw353","journal-title":"Clin Infect Dis"},{"key":"4497_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/IJN.S93069","volume":"11","author":"M Kalomiraki","year":"2015","unstructured":"Kalomiraki M, Thermos K, Chaniotakis NA (2015) Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications. Int J Nanomed 11:1\u201312. https:\/\/doi.org\/10.2147\/IJN.S93069","journal-title":"Int J Nanomed"},{"issue":"2","key":"4497_CR45","doi-asserted-by":"publisher","first-page":"346","DOI":"10.22377\/ajp.v18i02.5444","volume":"18","author":"SL Kardani","year":"2024","unstructured":"Kardani SL, Seth AK (2024) Nanocarrier-based formulations: regulatory challenges, ethical and safety considerations in pharmaceuticals. Asian J Pharm 18(2):346. https:\/\/doi.org\/10.22377\/ajp.v18i02.5444","journal-title":"Asian J Pharm"},{"key":"4497_CR46","doi-asserted-by":"publisher","first-page":"130808","DOI":"10.1016\/j.molstruc.2021.130844","volume":"1243","author":"V Karthik","year":"2021","unstructured":"Karthik V, Poornima S, Vigneshwaran A, Raj DPRDD, Subbaiya R, Manikandan S et al (2021) Nanoarchitectonics is an emerging drug\/gene delivery and targeting strategy\u2014A critical review. J Mol Struct 1243:130808. https:\/\/doi.org\/10.1016\/j.molstruc.2021.130844","journal-title":"J Mol Struct"},{"issue":"9","key":"4497_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms24097922","volume":"24","author":"PB Kasi","year":"2023","unstructured":"Kasi PB, Mallela VR, Ambrozkiewicz F, Trailin A, Li\u0161ka V, Hemminki K (2023) Theranostics nanomedicine applications for colorectal cancer and metastasis: recent advances. Int J Mol Sci 24(9):1\u201319. https:\/\/doi.org\/10.3390\/ijms24097922","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4497_CR48","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-021-02707-w","volume":"11","author":"J Khan","year":"2021","unstructured":"Khan J, Tarar SM, Gul I, Nawaz U, Arshad M (2021) Challenges of antibiotic resistance biofilms and potential combating strategies: a review. 3 Biotech 11(4):169. https:\/\/doi.org\/10.1007\/s13205-021-02707-w","journal-title":"3 Biotech"},{"key":"4497_CR49","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.addr.2017.07.015","volume":"124","author":"VV Khutoryanskiy","year":"2017","unstructured":"Khutoryanskiy VV (2017) Beyond pegylation: alternative surface-modification of nanoparticles with mucus-inert biomaterials. Adv Drug Deliv Rev 124:140\u2013149. https:\/\/doi.org\/10.1016\/j.addr.2017.07.015","journal-title":"Adv Drug Deliv Rev"},{"key":"4497_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-65688-5","volume":"10","author":"N Klubthawee","year":"2020","unstructured":"Klubthawee N, Adisakwattana P, Hanpithakpong W, Somsri S, Aunpad R (2020) A novel, rationally designed, hybrid antimicrobial peptide, inspired by Cathelicidin and aurein, exhibits membrane-active mechanisms against Pseudomonas aeruginosa. Sci Rep 10:9117. https:\/\/doi.org\/10.1038\/s41598-020-65688-5","journal-title":"Sci Rep"},{"issue":"4","key":"4497_CR51","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1128\/CMR.00051-05","volume":"19","author":"SM Koenig","year":"2006","unstructured":"Koenig SM, Truwit JD (2006) Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev 19(4):637\u2013657. https:\/\/doi.org\/10.1128\/CMR.00051-05","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"4497_CR52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.5487\/TR.2012.28.1.025","volume":"28","author":"JT Kwon","year":"2012","unstructured":"Kwon JT, Minai-Tehrani A, Hwang SK et al (2012) Acute pulmonary toxicity and body distribution of inhaled metallic silver nanoparticles. Toxicol Res 28(1):25\u201331. https:\/\/doi.org\/10.5487\/TR.2012.28.1.025","journal-title":"Toxicol Res"},{"key":"4497_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01153","volume":"10","author":"NY Lee","year":"2019","unstructured":"Lee NY, Ko WC, Hsueh PR (2019) Nanoparticles in the treatment of infections caused by multidrug-resistant organisms. Front Pharmacol 10:1153. https:\/\/doi.org\/10.3389\/fphar.2019.01153","journal-title":"Front Pharmacol"},{"issue":"5","key":"4497_CR54","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s11095-022-03379-8","volume":"40","author":"J Li","year":"2023","unstructured":"Li J, Zheng H, Leung SSY (2023) Pulmonary delivery of emerging antibacterials for bacterial lung infections treatment. Pharm Res 40(5):1057\u20131072. https:\/\/doi.org\/10.1007\/s11095-022-03379-8","journal-title":"Pharm Res"},{"issue":"44","key":"4497_CR55","doi-asserted-by":"publisher","first-page":"17698","DOI":"10.1039\/d3nr04362b","volume":"15","author":"W Lou","year":"2023","unstructured":"Lou W, Xie L, Xu L, Xu M, Xu F, Zhao Q et al (2023) Present and future of metal nanoparticles in tumor ablation therapy. Nanoscale 15(44):17698\u201317726. https:\/\/doi.org\/10.1039\/d3nr04362b","journal-title":"Nanoscale"},{"issue":"9","key":"4497_CR56","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1016\/S1473-3099(20)30327-3","volume":"20","author":"M Magana","year":"2020","unstructured":"Magana M, Pushpanathan M, Santos AL, Leanse L, Fernandez M, Ioannidis A et al (2020) The value of antimicrobial peptides in the age of resistance. Lancet Infect Dis 20(9):e216\u2013e230. https:\/\/doi.org\/10.1016\/S1473-3099(20)30327-3","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"4497_CR57","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG et al (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268\u2013281. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"4497_CR58","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/pharmaceutics11090448","volume":"11","author":"\u00c1 Martin-Serrano","year":"2019","unstructured":"Martin-Serrano \u00c1, G\u00f3mez R, Ortega P, de la Mata FJ (2019) Nanosystems as vehicles for the delivery of antimicrobial peptides (AMPs). Pharmaceutics 11(9):448. https:\/\/doi.org\/10.3390\/pharmaceutics11090448","journal-title":"Pharmaceutics"},{"issue":"10","key":"4497_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24109031","volume":"24","author":"A Mazurkiewicz-Pisarek","year":"2023","unstructured":"Mazurkiewicz-Pisarek A, Baran J, Ciach T (2023) Antimicrobial peptides: challenging journey to the pharmaceutical, biomedical, and cosmeceutical use. Int J Mol Sci 24(10):9031. https:\/\/doi.org\/10.3390\/ijms24109031","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4497_CR60","first-page":"445","volume":"95","author":"IE Mba","year":"2022","unstructured":"Mba IE, Nweze EI (2022) Antimicrobial peptides therapy: an emerging alternative for treating Drug-Resistant bacteria. Yale J Biol Med 95(4):445\u2013463 PMID:36568838; PMCID:PMC9765339","journal-title":"Yale J Biol Med"},{"issue":"10","key":"4497_CR61","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.7150\/thno.38069","volume":"10","author":"P Mi","year":"2020","unstructured":"Mi P (2020) Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics. Theranostics 10(10):4557\u20134588. https:\/\/doi.org\/10.7150\/thno.38069","journal-title":"Theranostics"},{"key":"4497_CR62","doi-asserted-by":"publisher","first-page":"990","DOI":"10.4187\/respcare.02380","volume":"58","author":"C Mietto","year":"2013","unstructured":"Mietto C, Pinciroli R, Patel N, Berra L (2013) Ventilator associated pneumonia: evolving definitions and preventive strategies. Respir Care 58:990\u20131007. https:\/\/doi.org\/10.4187\/respcare.02380","journal-title":"Respir Care"},{"key":"4497_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9692","volume":"6","author":"MA Miller","year":"2015","unstructured":"Miller MA, Zheng YR, Gadde S, Pfirschke C, Zope H, Engblom C (2015) Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug. Nat Commun 6:8692. https:\/\/doi.org\/10.1038\/ncomms9692","journal-title":"Nat Commun"},{"key":"4497_CR64","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.69430","volume-title":"Contemporary topics of pneumonia","author":"V Monteiro-Neto","year":"2017","unstructured":"Monteiro-Neto V, Lima-Neto LG, Abreu AG, Monteiro CRAV (2017) Microbiology of Ventilator-Associated pneumonia. In: Chroneos ZC (ed) Contemporary topics of pneumonia. IntechOpen, London. doi:https:\/\/doi.org\/10.5772\/intechopen.69430."},{"key":"4497_CR65","doi-asserted-by":"publisher","first-page":"5178","DOI":"10.1182\/blood-2010-08-304667","volume":"117","author":"AC Morris","year":"2011","unstructured":"Morris AC, Brittan M, Wilkinson TS, McAuley DF, Antonelli J, McCulloch C, Barr LC, McDonald NA, Dhaliwal K, Jones RO, Mackellar A, Haslett C, Hay AW, Swann DG, Anderson N, Laurenson IF, Davidson DJ, Rossi AG, Walsh TS, Simpson AJ (2011) C5a-mediated neutrophil dysfunction is RhoA-dependent and predicts infection in critically ill patients. Blood 117:5178\u20135188. https:\/\/doi.org\/10.1182\/blood-2010-08-304667","journal-title":"Blood"},{"issue":"6","key":"4497_CR66","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.24272\/j.issn.2095-8137.2023.246","volume":"44","author":"J Mwangi","year":"2023","unstructured":"Mwangi J, Kamau PM, Thuku RC, Lai R (2023) Design methods for antimicrobial peptides with improved performance. Zool Res 44(6):1095\u20131114. https:\/\/doi.org\/10.24272\/j.issn.2095-8137.2023.246","journal-title":"Zool Res"},{"issue":"2","key":"4497_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17020207","volume":"17","author":"H Omidian","year":"2025","unstructured":"Omidian H, Wilson RL (2025) PLGA-based strategies for intranasal and pulmonary applications. Pharmaceutics 17(2):207. https:\/\/doi.org\/10.3390\/pharmaceutics17020207","journal-title":"Pharmaceutics"},{"issue":"4","key":"4497_CR68","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms13040722","volume":"13","author":"OA Omoteso","year":"2025","unstructured":"Omoteso OA, Fadaka AO, Walker RB, Khamanga SM (2025) Innovative strategies for combating multidrug-resistant tuberculosis: advances in drug delivery systems and treatment. Microorganisms 13(4):722. https:\/\/doi.org\/10.3390\/microorganisms13040722","journal-title":"Microorganisms"},{"key":"4497_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105517","volume":"94","author":"VK Panthi","year":"2024","unstructured":"Panthi VK, Fairfull-Smith KE, Islam N (2024) Antibiotic loaded inhalable liposomal nanoparticles against lower respiratory tract infections: challenges, recent advances, and future perspectives. J Drug Deliv Sci Technol 94:105517. https:\/\/doi.org\/10.1016\/j.jddst.2024.105517","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"4497_CR70","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/0970-2113.92361","volume":"29","author":"JS Patil","year":"2012","unstructured":"Patil JS, Sarasija S (2012) Pulmonary drug delivery strategies: a concise, systematic review. Lung India 29(1):44\u201349. https:\/\/doi.org\/10.4103\/0970-2113.92361","journal-title":"Lung India"},{"key":"4497_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtice.2025.106157","author":"AR Patra","year":"2025","unstructured":"Patra AR, Pattnaik A, Ghosh P (2025) The latest breakthroughs in green and hybrid nanoparticle synthesis for multifaceted environmental applications. J Taiwan Inst Chem Eng. https:\/\/doi.org\/10.1016\/j.jtice.2025.106157","journal-title":"J Taiwan Inst Chem Eng"},{"issue":"1","key":"4497_CR72","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nrd2153","volume":"6","author":"JS Patton","year":"2007","unstructured":"Patton JS, Byron PR (2007) Inhaling medicines: delivering drugs to the body through the lungs. Nat Rev Drug Discov 6(1):67\u201374. https:\/\/doi.org\/10.1038\/nrd2153","journal-title":"Nat Rev Drug Discov"},{"key":"4497_CR73","doi-asserted-by":"publisher","first-page":"8270","DOI":"10.1039\/D4NR05114A","volume":"17","author":"L Peng","year":"2025","unstructured":"Peng L, Gao Z, Liang Y, Guo X, Zhang Q, Cui D (2025) Nanoparticle-based drug delivery systems: opportunities and challenges in the treatment of esophageal squamous cell carcinoma (ESCC). Nanoscale 17:8270\u20138288. https:\/\/doi.org\/10.1039\/D4NR05114A","journal-title":"Nanoscale"},{"key":"4497_CR74","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2024.1423500","volume":"12","author":"V P\u00e9rez-P\u00e9rez","year":"2024","unstructured":"P\u00e9rez-P\u00e9rez V, Jim\u00e9nez-Mart\u00ednez C, Gonz\u00e1lez-Escobar JL, Corzo-R\u00edos LJ (2024) Exploring the impact of encapsulation on the stability and bioactivity of peptides extracted from botanical sources: trends and opportunities. Front Chem 12:1423500. https:\/\/doi.org\/10.3389\/fchem.2024.1423500","journal-title":"Front Chem"},{"key":"4497_CR75","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.7150\/thno.14843","volume":"6","author":"C Qian","year":"2016","unstructured":"Qian C, Chen Y, Zhu S, Yu J, Zhang L, Feng P et al (2016) ATP-responsive and near-infrared-emissive nanocarriers for anticancer drug delivery and real-time imaging. Theranostics 6:1053\u20131064. https:\/\/doi.org\/10.7150\/thno.14843","journal-title":"Theranostics"},{"key":"4497_CR76","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1378\/chest.122.6.2115","volume":"122","author":"J Rello","year":"2002","unstructured":"Rello J, Ollendorf D, Oster G, Vera-Llonch M, Bellm L, Redman R et al (2002) Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 122:2115\u20132121. https:\/\/doi.org\/10.1378\/chest.122.6.2115","journal-title":"Chest"},{"issue":"Suppl 2","key":"4497_CR77","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1159\/000445116","volume":"25","author":"M Rudokas","year":"2016","unstructured":"Rudokas M, Najlah M, Alhnan MA, Elhissi A (2016) Liposome delivery systems for inhalation: a critical review highlighting formulation issues and anticancer applications. Med Princ Pract 25(Suppl 2):60\u201372. https:\/\/doi.org\/10.1159\/000445116","journal-title":"Med Princ Pract"},{"key":"4497_CR78","doi-asserted-by":"publisher","unstructured":"Riego Sintes J, Bl\u00e1zquez M, Moya SE, V\u00e1zquez-Campos S (2012) Safety issues and regulatory challenges of nanomaterials. Luxembourg: Publications Office of the European Union; Jan. Report No.: ISBN 978-92-79-28071-9.. https:\/\/doi.org\/10.2788\/76363","DOI":"10.2788\/76363"},{"issue":"10","key":"4497_CR79","doi-asserted-by":"publisher","first-page":"e70629","DOI":"10.7759\/cureus.70629","volume":"16","author":"K Sahoo","year":"2024","unstructured":"Sahoo K, Meshram S (2024) Biofilm formation in chronic infections: A comprehensive review of Pathogenesis, clinical Implications, and novel therapeutic approaches. Cureus 16(10):e70629. https:\/\/doi.org\/10.7759\/cureus.70629","journal-title":"Cureus"},{"issue":"26","key":"4497_CR80","doi-asserted-by":"publisher","first-page":"27853","DOI":"10.1021\/acsomega.4c02343","volume":"9","author":"O Sedighi","year":"2024","unstructured":"Sedighi O, Bednarke B, Sherriff H, Doiron AL (2024) Nanoparticle-based strategies for managing biofilm infections in wounds: a comprehensive review. ACS Omega 9(26):27853\u201327871. https:\/\/doi.org\/10.1021\/acsomega.4c02343","journal-title":"ACS Omega"},{"issue":"1","key":"4497_CR81","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.athoracsur.2018.08.008","volume":"107","author":"TR Semenkovich","year":"2019","unstructured":"Semenkovich TR, Frederiksen C, Hudson JL, Subramanian M, Kollef MH, Patterson GA et al (2019) Postoperative pneumonia prevention in pulmonary resections: a feasibility pilot study. Ann Thorac Surg 107(1):262\u2013270. https:\/\/doi.org\/10.1016\/j.athoracsur.2018.08.008","journal-title":"Ann Thorac Surg"},{"issue":"2","key":"4497_CR82","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1055\/s-0041-1731136","volume":"14","author":"S Shah","year":"2021","unstructured":"Shah S, Rampal R, Thakkar P, Poojary S, Ladi S (2021) The prevalence and antimicrobial susceptibility pattern of Gram-positive pathogens: three-year study at a tertiary care hospital in Mumbai, India. J Lab Physicians 14(2):109\u2013114. https:\/\/doi.org\/10.1055\/s-0041-1731136","journal-title":"J Lab Physicians"},{"issue":"4","key":"4497_CR83","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.bjid.2018.06.002","volume":"22","author":"ARAD Silva","year":"2018","unstructured":"Silva ARAD, Silva TCD, Bom GJT, Vasconcelos RMB, Junior RS (2018) Ventilator-associated pneumonia agents in Brazilian neonatal intensive care units - a systematic review. Braz J Infect Dis 22(4):338\u2013344. https:\/\/doi.org\/10.1016\/j.bjid.2018.06.002","journal-title":"Braz J Infect Dis"},{"issue":"Pt A","key":"4497_CR84","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","volume":"99","author":"JS Suk","year":"2016","unstructured":"Suk JS, Xu Q, Kim N, Hanes J, Ensign LM (2016) Pegylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv Drug Deliv Rev 99(Pt A):28\u201351. https:\/\/doi.org\/10.1016\/j.addr.2015.09.012","journal-title":"Adv Drug Deliv Rev"},{"key":"4497_CR85","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1059343","volume":"14","author":"ME Taghavizadeh Yazdi","year":"2023","unstructured":"Taghavizadeh Yazdi ME, Qayoomian M, Beigoli S, Boskabady MH (2023) Recent advances in nanoparticle applications in respiratory disorders: a review. Front Pharmacol 14:1059343. https:\/\/doi.org\/10.3389\/fphar.2023.1059343","journal-title":"Front Pharmacol"},{"issue":"10","key":"4497_CR86","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11101417","volume":"11","author":"J Talapko","year":"2022","unstructured":"Talapko J, Me\u0161trovi\u0107 T, Juzba\u0161i\u0107 M, Tomas M, Eri\u0107 S, Horvat Aleksijevi\u0107 L et al (2022) Antimicrobial peptides\u2014mechanisms of action, antimicrobial effects and clinical applications. Antibiotics 11(10):1417. https:\/\/doi.org\/10.3390\/antibiotics11101417","journal-title":"Antibiotics"},{"key":"4497_CR87","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40005-021-00525-z","volume":"51","author":"RK Thapa","year":"2021","unstructured":"Thapa RK, Diep DB, T\u00f8nnesen HH (2021) Nanomedicine-based antimicrobial peptide delivery for bacterial infections: recent advances and future prospects. J Pharm Investig 51:377\u2013398. https:\/\/doi.org\/10.1007\/s40005-021-00525-z","journal-title":"J Pharm Investig"},{"issue":"10","key":"4497_CR88","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1111\/1462-2920.12155","volume":"15","author":"BS Tseng","year":"2013","unstructured":"Tseng BS, Zhang W, Harrison JJ et al (2013) The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Environ Microbiol 15(10):2865\u20132878. https:\/\/doi.org\/10.1111\/1462-2920.12155","journal-title":"Environ Microbiol"},{"key":"4497_CR89","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2019.00406","volume":"7","author":"C Velino","year":"2019","unstructured":"Velino C, Carella F, Adamiano A, Sanguinetti M, Vitali A, Catalucci D et al (2019) Nanomedicine approaches for the pulmonary treatment of cystic fibrosis. Front Bioeng Biotechnol 7:406. https:\/\/doi.org\/10.3389\/fbioe.2019.00406","journal-title":"Front Bioeng Biotechnol"},{"issue":"4","key":"4497_CR90","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.apsb.2021.02.022","volume":"11","author":"IMO Viana","year":"2021","unstructured":"Viana IMO, Roussel S, Defr\u00eane J, Lima EM, Barab\u00e9 F, Bertrand N (2021) Innate and adaptive immune responses toward nanomedicines. Acta Pharm Sin B 11(4):852\u2013870. https:\/\/doi.org\/10.1016\/j.apsb.2021.02.022","journal-title":"Acta Pharm Sin B"},{"key":"4497_CR91","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1001\/jama.1995.03530080055041","volume":"274","author":"JL Vincent","year":"1995","unstructured":"Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin MH et al (1995) The prevalence of nosocomial infection in intensive care units in Europe. JAMA 274:639\u2013644. https:\/\/doi.org\/10.1001\/jama.1995.03530080055041","journal-title":"JAMA"},{"key":"4497_CR92","volume-title":"Next-generation drug delivery systems","author":"RS Wakchaure","year":"2025","unstructured":"Wakchaure RS, Dhial K, Pathak A (2025) Ethical and safety considerations in drug delivery systems. In: Pathak A (ed) Next-generation drug delivery systems, 1st edn. Springer, US","edition":"1"},{"key":"4497_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcsw.2024.100135","volume":"12","author":"Y Wang","year":"2024","unstructured":"Wang Y, Song M, Chang W (2024) Antimicrobial peptides and proteins against drug-resistant pathogens. The Cell Surface 12:100135. https:\/\/doi.org\/10.1016\/j.tcsw.2024.100135","journal-title":"The Cell Surface"},{"key":"4497_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.05.028","volume":"175","author":"C Wang","year":"2021","unstructured":"Wang C, Hong T, Cui P, Wang J, Xia J (2021) Antimicrobial peptides towards clinical application: delivery and formulation. Adv Drug Deliv Rev 175:113818. https:\/\/doi.org\/10.1016\/j.addr.2021.05.028","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"4497_CR95","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1021\/acsbiomaterials.0c01084","volume":"7","author":"L Yang","year":"2021","unstructured":"Yang L, Liu Y, Wang N, Wang H, Wang K, Luo XL et al (2021) Albumin-based LL37 peptide nanoparticles as a sustained release system against Pseudomonas aeruginosa lung infection. ACS Biomater Sci Eng 7(5):1817\u20131826. https:\/\/doi.org\/10.1021\/acsbiomaterials.0c01084","journal-title":"ACS Biomater Sci Eng"},{"key":"4497_CR96","doi-asserted-by":"publisher","DOI":"10.1002\/marc.202401046","author":"Z Yuan","year":"2025","unstructured":"Yuan Z, Kang J, Wu S, Dong A, Wu R (2025) Advances in antimicrobial peptide-based biomaterials for combating multidrug-resistant bacterial infections. Macromol Rapid Commun. https:\/\/doi.org\/10.1002\/marc.202401046","journal-title":"Macromol Rapid Commun"},{"issue":"41","key":"4497_CR97","doi-asserted-by":"publisher","first-page":"e2305215","DOI":"10.1002\/adma.202305215","volume":"35","author":"P Zhang","year":"2023","unstructured":"Zhang P, Li Z, Cao W, Tang J, Xia Y, Peng L et al (2023) A PD-L1 antibody-conjugated PAMAM dendrimer nanosystem for simultaneously inhibiting Glycolysis and promoting immune response in fighting breast cancer. Adv Mater 35(41):e2305215. https:\/\/doi.org\/10.1002\/adma.202305215","journal-title":"Adv Mater"},{"issue":"1","key":"4497_CR98","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06321-9","volume":"23","author":"S Zheng","year":"2025","unstructured":"Zheng S, Tu Y, Li B, Qu G, Li A, Peng X, Li S, Shao C (2025) Antimicrobial peptide biological activity, delivery systems and clinical translation status and challenges. J Transl Med 23(1):292. https:\/\/doi.org\/10.1186\/s12967-025-06321-9","journal-title":"J Transl Med"},{"key":"4497_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2019.04.011","volume":"20","author":"M Zhou","year":"2019","unstructured":"Zhou M, Wei W, Chen X, Xu X, Zhang X, Zhang X (2019) Ph and redox dual responsive carrier-free anticancer drug nanoparticles for targeted delivery and synergistic therapy. Nanomedicine 20:102008. https:\/\/doi.org\/10.1016\/j.nano.2019.04.011","journal-title":"Nanomedicine"},{"key":"4497_CR100","doi-asserted-by":"publisher","DOI":"10.1186\/cc10352","volume":"15","author":"PS Zolfaghari","year":"2011","unstructured":"Zolfaghari PS, Wyncoll DL (2011) The tracheal tube: gateway to ventilator-associated pneumonia. Crit Care 15:310. https:\/\/doi.org\/10.1186\/cc10352","journal-title":"Crit Care"},{"issue":"11","key":"4497_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/nano12111855","volume":"12","author":"TX Zong","year":"2022","unstructured":"Zong TX, Silveira AP, Morais JAV, Sampaio MC, Muehlmann LA, Zhang J et al (2022) Recent advances in antimicrobial nano-drug delivery systems. Nanomaterials 12(11):1855. https:\/\/doi.org\/10.3390\/nano12111855","journal-title":"Nanomaterials"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04497-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-025-04497-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04497-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T20:03:43Z","timestamp":1763669023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-025-04497-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,18]]},"references-count":101,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4497"],"URL":"https:\/\/doi.org\/10.1007\/s00203-025-04497-8","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,18]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"316"}}